Evaluate the Safety and Effectiveness of the enVista® One-Piece Hydrophobic Acrylic Trifocal Intraocular Lens
A Prospective, Multicenter, Randomized, Active-Controlled Clinical Study to Evaluate the Safety and Effectiveness of the enVista® One-Piece Hydrophobic Acrylic Trifocal Intraocular Lens in Subjects Undergoing Cataract Extraction
Sponsor: Bausch & Lomb Incorporated
This NA trial investigates Cataract and is currently completed. Bausch & Lomb Incorporated leads this study, which shows 17 recorded versions since 2018 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
17 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Jan 2025 — Sep 2025 [monthly]
Completed NA
-
Sep 2024 — Jan 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2024 — Jul 2024 [monthly]
Completed NA
▶ Show 12 earlier versions
-
Nov 2023 — Jan 2024 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Aug 2023 — Nov 2023 [monthly]
Active Not Recruiting NA
-
Apr 2023 — Aug 2023 [monthly]
Active Not Recruiting NA
-
Jul 2022 — Apr 2023 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
May 2022 — Jul 2022 [monthly]
Recruiting NA
-
Feb 2022 — May 2022 [monthly]
Recruiting NA
-
Sep 2021 — Feb 2022 [monthly]
Recruiting NA
-
Feb 2021 — Sep 2021 [monthly]
Recruiting NA
-
Jan 2021 — Feb 2021 [monthly]
Recruiting NA
-
Feb 2020 — Jan 2021 [monthly]
Recruiting NA
-
Nov 2019 — Feb 2020 [monthly]
Recruiting NA
-
Aug 2018 — Nov 2019 [monthly]
Recruiting NA
First recorded
May 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Bausch & Lomb Incorporated
For direct contact, visit the study record on ClinicalTrials.gov .